NVNO

enVVeno Medical Corporation Common Stock

6.35

USD

-0.62

-8.84%

Nov 06, 11:55 UTC -5

Open

enVVeno Medical Corporation Common Stock (NVNO) Earnings

NVNO Earnings Reports

Positive Surprise Ratio

NVNO beat 13 of 25 last estimates.

52%

Next Report

Date of Next Report

Mar 24, 2027

Estimate for Q4 26 (Revenue/ EPS)

-$2.39

Implied change from Q3 26 (Revenue/ EPS)

-62.00%

Implied change from Q4 25 (Revenue/ EPS)

enVVeno Medical Corporation Common Stock earnings per share and revenue

On Oct 29, 2026, NVNO reported earnings of -6.29 USD per share (EPS) for Q3 26, missing the estimate of -3.33 USD, resulting in a -88.58% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.08% price change (close before vs. close after earnings).

Looking ahead to Q4 26, -- analysts forecast an EPS of -2.39 USD, with revenue projected to reach -- USD, implying an decrease of -62.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

CVRx, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.50

Actual

-$0.52

Surprise

-2.91%

Mettler-Toledo International

Report Date

Nov 05, 2026 For Q3 26

Estimate

$12.21

Actual

$12.57

Surprise

+2.90%

Teleflex Incorporated

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.92

Actual

$2.63

Surprise

+36.82%

Pulse Biosciences, Inc Common Stock (DE)

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.37

Actual

-$0.32

Surprise

+14.05%

TransMedics Group, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.29

Actual

$0.51

Surprise

+71.31%

Tandem Diabetes Care, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.24

Actual

-$0.10

Surprise

+59.55%

Artivion, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.06

Actual

$0.08

Surprise

+228.00%

Mobia Medical, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.47

Actual

-$0.52

Surprise

-9.04%

Treace Medical Concepts, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.25

Actual

-$0.19

Surprise

+26.67%

Inogen Inc

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.14

Actual

-$0.56

Surprise

-285.41%

FAQ

What were enVVeno Medical Corporation Common Stock's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, enVVeno Medical Corporation Common Stock reported EPS of -$6.29, missing estimates by -88.58%, and revenue of $0.00, 0% as expectations.

How did the market react to enVVeno Medical Corporation Common Stock's Q3 2026 earnings?

The stock price moved up 4.08%, changed from $6.75 before the earnings release to $7.02 the day after.

When is enVVeno Medical Corporation Common Stock expected to report next?

The next earning report is scheduled for Mar 24, 2027.

What are the forecasts for enVVeno Medical Corporation Common Stock's next earnings report?

Based on -- analysts, enVVeno Medical Corporation Common Stock is expected to report EPS of -$2.39 and revenue of -- for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.